カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/04 | 1,102 | 1,102 | 1,080 | 1,081 | -22 | -2% | 11,300 |
| 2022/11/02 | 1,115 | 1,115 | 1,103 | 1,103 | -12 | -1.1% | 3,200 |
| 2022/11/01 | 1,120 | 1,120 | 1,101 | 1,115 | -8 | -0.7% | 11,200 |
| 2022/10/31 | 1,148 | 1,148 | 1,120 | 1,123 | -16 | -1.4% | 15,400 |
| 2022/10/28 | 1,090 | 1,139 | 1,088 | 1,139 | +56 | +5.2% | 59,400 |
| 2022/10/27 | 1,079 | 1,097 | 1,066 | 1,083 | +4 | +0.4% | 15,800 |
| 2022/10/26 | 1,077 | 1,083 | 1,063 | 1,079 | +3 | +0.3% | 29,200 |
| 2022/10/25 | 1,105 | 1,165 | 1,065 | 1,076 | -26 | -2.4% | 128,800 |
| 2022/10/24 | 1,110 | 1,121 | 1,100 | 1,102 | -2 | -0.2% | 20,100 |
| 2022/10/21 | 1,072 | 1,106 | 1,072 | 1,104 | +36 | +3.4% | 17,800 |
| 2022/10/20 | 1,066 | 1,071 | 1,060 | 1,068 | +2 | +0.2% | 5,800 |
| 2022/10/19 | 1,061 | 1,070 | 1,057 | 1,066 | +3 | +0.3% | 8,600 |
| 2022/10/18 | 1,073 | 1,076 | 1,059 | 1,063 | -10 | -0.9% | 15,300 |
| 2022/10/17 | 1,093 | 1,093 | 1,059 | 1,073 | -8 | -0.7% | 13,500 |
| 2022/10/14 | 1,100 | 1,108 | 1,062 | 1,081 | +26 | +2.5% | 75,000 |
| 2022/10/13 | 1,032 | 1,163 | 1,031 | 1,055 | +36 | +3.5% | 325,300 |
| 2022/10/12 | 1,032 | 1,032 | 1,014 | 1,019 | -8 | -0.8% | 4,600 |
| 2022/10/11 | 1,032 | 1,032 | 1,016 | 1,027 | -7 | -0.7% | 5,400 |
| 2022/10/07 | 1,034 | 1,043 | 1,025 | 1,034 | -4 | -0.4% | 2,300 |
| 2022/10/06 | 1,038 | 1,038 | 1,016 | 1,038 | ±0 | ±0% | 3,800 |
| 2022/10/05 | 1,032 | 1,038 | 1,023 | 1,038 | +6 | +0.6% | 2,600 |
| 2022/10/04 | 1,019 | 1,032 | 1,014 | 1,032 | +23 | +2.3% | 5,100 |
| 2022/10/03 | 1,004 | 1,022 | 992 | 1,009 | -7 | -0.7% | 5,400 |
| 2022/09/30 | 1,011 | 1,021 | 1,004 | 1,016 | -4 | -0.4% | 6,000 |
| 2022/09/29 | 1,002 | 1,027 | 1,002 | 1,020 | +18 | +1.8% | 5,500 |
| 2022/09/28 | 1,002 | 1,011 | 995 | 1,002 | +1 | +0.1% | 8,800 |
| 2022/09/27 | 1,000 | 1,017 | 1,000 | 1,001 | +2 | +0.2% | 11,900 |
| 2022/09/26 | 1,019 | 1,019 | 990 | 999 | -28 | -2.7% | 25,200 |
| 2022/09/22 | 1,015 | 1,027 | 1,010 | 1,027 | +2 | +0.2% | 19,600 |
| 2022/09/21 | 1,034 | 1,034 | 1,021 | 1,025 | -9 | -0.9% | 3,800 |
| 2022/09/20 | 1,046 | 1,046 | 1,030 | 1,034 | -12 | -1.1% | 8,700 |
| 2022/09/16 | 1,041 | 1,050 | 1,035 | 1,046 | -4 | -0.4% | 5,600 |
| 2022/09/15 | 1,060 | 1,060 | 1,047 | 1,050 | -6 | -0.6% | 3,200 |
| 2022/09/14 | 1,037 | 1,056 | 1,037 | 1,056 | +4 | +0.4% | 1,600 |
| 2022/09/13 | 1,053 | 1,059 | 1,050 | 1,052 | ±0 | ±0% | 3,100 |
| 2022/09/12 | 1,058 | 1,067 | 1,043 | 1,052 | +2 | +0.2% | 7,700 |
| 2022/09/09 | 1,031 | 1,050 | 1,031 | 1,050 | +19 | +1.8% | 5,000 |
| 2022/09/08 | 1,041 | 1,041 | 1,028 | 1,031 | +3 | +0.3% | 5,500 |
| 2022/09/07 | 1,054 | 1,054 | 1,026 | 1,028 | -21 | -2% | 7,100 |
| 2022/09/06 | 1,038 | 1,052 | 1,035 | 1,049 | +7 | +0.7% | 8,200 |
| 2022/09/05 | 1,040 | 1,044 | 1,026 | 1,042 | ±0 | ±0% | 8,700 |
| 2022/09/02 | 1,055 | 1,055 | 1,037 | 1,042 | -11 | -1% | 10,200 |
| 2022/09/01 | 1,062 | 1,062 | 1,045 | 1,053 | -16 | -1.5% | 11,700 |
| 2022/08/31 | 1,066 | 1,069 | 1,060 | 1,069 | -2 | -0.2% | 5,300 |
| 2022/08/30 | 1,067 | 1,074 | 1,067 | 1,071 | -2 | -0.2% | 4,200 |
| 2022/08/29 | 1,080 | 1,080 | 1,061 | 1,073 | -11 | -1% | 14,400 |
| 2022/08/26 | 1,088 | 1,091 | 1,083 | 1,084 | -10 | -0.9% | 7,200 |
| 2022/08/25 | 1,094 | 1,098 | 1,079 | 1,094 | +1 | +0.1% | 10,800 |
| 2022/08/24 | 1,087 | 1,095 | 1,084 | 1,093 | +9 | +0.8% | 4,800 |
| 2022/08/23 | 1,109 | 1,109 | 1,084 | 1,084 | -26 | -2.3% | 18,500 |
601～
650
件表示中 / 3682件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 114,300円 | +6.8% | -13.8% | 3.06% | 8.76倍 | 0.75倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ティムス | 13,900円 | - | - | 0.00% | - | 2.01倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国ＣＯＲＸＥＬ社に導出 |
| ペルセウス | 38,000円 | +20.0% | - | 0.00% | - | 3.18倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
| ＤＷＴＩ | 11,000円 | -15.1% | - | 0.00% | - | 6.80倍 |
|
三重大学発創薬ベンチャー。プロテインキナーゼ阻害剤開発技術はじめ眼病治療薬開発に集中 |
| カルナバイオ | 25,200円 | +13.5% | - | 0.00% | - | 1.94倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム
